Growing Preference for Minimally Invasive Surgery Driving Laser Cancer Therapy Market

Timely diagnosis due to the availability of modern technologies and consequent demand for effective treatment will drive growth laser cancer therapy market. The global laser cancer therapy market is expected to surge due to the increasing prevalence of cancer such as melanoma, metastatic, and colorectal cancer.

According to the American Institute for Cancer Research, more than 18 million cases of cancer were estimated in the year 2018, out of which 9.5 million were women and 8.5 million were men. Besides this, breast and lung cancers were the most common cancers found across the globe. There is increasing demand to prevent the rising incidence of cancer. This is expected to drive the growth of the laser cancer therapy market.

In the U.S., over 44% of the female diagnosed with breast cancer and managed to survive post-treatment in 2019, as per a study by the American Cancer Society. Therefore, the demand for effective treatment to curb the incidence of cancer will create growth opportunities for the market.

Despite growth registered in the last few years, the COVID-19 outbreak has slowed down the expansion of the market due to the mandatory closures of consumer markets, shrinking the economy across the globe. The outbreak also has disrupted treatment available for other chronic ailments, as the healthcare industry continued to focus on curbing the mounting cases of people affected by the pandemic worldwide. Nonetheless, increasing government initiatives and investment in advanced healthcare are expected to drive the market.

“Key players operating in the market are focusing on introducing technologically advanced products. Besides this, they are acquiring software companies to help them expand their portfolio and strengthen their footprint in the global market,” said a lead analyst at Fact.MR